News & media

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: J O Hambro Capital Management

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: J O Hambro Capital Management

  • COMPANY ANNOUNCEMENT

    Zealand Pharma completes registration of capital increase

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

  • COMPANY ANNOUNCEMENT

    Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion

  • PRESS RELEASE

    Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma at December 29, 2023

  • COMPANY ANNOUNCEMENT

    U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing facility

  • PRESS RELEASE

    Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

  • PRESS RELEASE

    Zealand Pharma to highlight obesity pipeline at R&D Event on December 5

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Adam ALR0631

    Adam Steensberg - President and Chief Executive Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Utpal Singh 1

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Utpal Singh 2

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Steven Johnson

    Steven Johnson - Executive Vice President, Chief Development Officer

  • Eric Cox ALR8394

    Eric Cox - Executive Vice President, Chief Commercial Officer

Research and development

Sustainability

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts